Outlook Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, manufacturing, and commercializing complex biosimilar therapeutics in immunology and oncology disease areas. Its lead clinical program is ONS-5010, a proprietary ophthalmic bevacizumab product candidate that is in Phase I clinical trial for the treatment of wet age related macular degeneration. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in December 2018. The company was founded in 2010 and is headquartered in Cranbury, New Jer... view company details
Welcome to the LinkedIn page of the Oklahoma Department of Human Services! Follow this page for information about career opportunities and news about DHS. Our mission: We improve the quality of life of vulnerable Oklahomans by increasing people's ability to lead safer, healthier, more independent and productive lives. Our vision: DHS provides help and offers hope to vulnerable Oklahomans through stronger practices, involved communities and a caring and engaged workforce. See our current career opportunities at the following link: https://www.jobapscloud.com/OK/?Keyword=&Loc=&DeptNumber=830000&... view company details
Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidates include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis; and novel anthrax vaccine candidates, such as Px563L and RPA563 that have completed Phase Ia clinical study. The company also develops PF582, a biosimilar candidate to Lucentis; PF529, a biosimilar to Neulasta; and hematology/oncology products, including PF743, a recombinant crisantaspase, as well as PF745, a re... view company details
PAVmed Inc. operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Its product pipeline also comprises NextCath, a self-anchoring catheter; NextFlo, a disposable infusion system; and Caldus, a disposable tissue ablation device. The company was formerly known as PAXmed ... view company details
Protalex, Inc. focuses on the development of biopharmaceutical drugs for treating autoimmune and inflammatory diseases in the United States. The company targets a range of autoimmune diseases, such as rheumatoid arthritis (RA), immune thrombocytopenia (ITP), psoriasis, myasthenia gravis, chronic idiopathic demyelinating polyneuropathy, and pemphigus. Its lead product candidate is PRTX-100, an immunomodulatory therapy, a highly-purified form of staphylococcal protein A, which is in Phase I/II open-label, dose-escalating study for the treatment of patients with persistent/chronic ITP; and Phase ... view company details
At Potential Inc. our vision is for every person with autism to lead a successful life of value. Our mission as a non-profit organization is to assist children and adults with autism to reach their full educational, social and emotional potential by developing and applying innovative, evidence-based approaches. Potential, Inc. is dedicated to providing high-quality direct services, consultation, community outreach and education for families and professionals. We serve ages 1-64 in our clinic, school, and in the community, schools, and homes. view company details
Ritter Pharmaceuticals, Inc. develops and sells therapeutic products that modulate the gut microbiome to treat digestive disorders and gastrointestinal diseases. Its lead product candidate is RP-G28, an orally administered galacto-oligosaccharide that is in Phase III clinical trials for the treatment of lactose intolerance. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California. view company details
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary subcutaneous formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients outside of the acute care setting. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for t... view company details
Savara Inc. operates as an orphan lung disease company. Its lead product candidate includes Molgradex, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis; and in Phase IIa development stage for treating nontuberculous mycobacterial lung infection. The company is also developing AeroVanc, an inhaled vancomycin that is in Phase III stage for the treatment of methicillin-resistant Staphylococcus aureus lung infection in individuals living with cystic fibrosis. Savara Inc. is headquarte... view company details
Solitario Zinc Corp., an exploration stage company, engages in the acquisition, exploration, and development of zinc properties in North and South America. It primarily owns a 39% interest in the Florida Canyon zinc project located in northern Peru; and a 50% interest in the Lik zinc-lead-silver property located in Northwest Alaska. The company also owns the La Promesa gold exploration project; and an 85% interest in the Chambara exploration project located in Peru. The company was formerly known as Solitario Exploration & Royalty Corp. and changed its name to Solitario Zinc Corp. in July 2017... view company details
South Puget Sound Community College supports student success and builds prosperity by collaborating with leaders in industry, education, and our community to offer innovative, accessible, and affordable learning experiences. We employ devoted people who mirror the diversity of our community and contribute to an inclusive, welcoming environment. By investing in the creativity of our staff and faculty, we construct clear and compelling pathways that lead our students to successful outcomes on their educational journeys. We are fiscally strong and our mindful use of technology embedded in purpose... view company details
Welcome! We in Maine take pride in our quality of life, our entrepreneurial spirit, and our strong, independent heritage. Our motto'"Dirigo" or "I lead" ' reflects our sense of place, as the first state that greets the sun each morning, as well as our sense of prideā¦pride in our craftsmanship, our work ethic and our people. No matter where you work in Maine you find a real sense of authenticity. From our small cities to our rural communities, Maine offers a skilled and committed workforce, an unmatched transportation and information technology infrastructure, and an open-for-business attitude ... view company details
At Thomas Industrial Coatings, we take tremendous pride in every single service we offer - concrete coatings, fireproofing, industrial coating applications and lead abatement just to name a few. There's never a scenario we're uncomfortable with - just look at all the markets we've served and the services we offer. Our home office is in Pevely, Missouri (south of St. Louis) and we have satellite offices throughout the country. We've worked in almost every state and we have more than $9 million in state-of-the-art equipment. To sum it up, we can work anywhere and on anything. As our owner himsel... view company details
Xenetic Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. The company's lead investigational product candidate is oncology therapeutic XBIO-101 (sodium cridanimod) for the treatment of progesterone resistant endometrial cancer. Its proprietary drug development platform, PolyXen, enables next-generation biologic drugs by improving their half-life and other pharmacological properties. The company has a research, development, license, and supply agreements wit... view company details
BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their applications. The company's products include Vector Segment Technology SDK, a biometric software development kit that provides developers the ability to incorporate its biometric capabilities int... view company details
Charter Communications, Inc., through its subsidiaries, provides cable services to residential and commercial customers in the United States. It offers subscription-based video services, including video on demand, high definition television, digital video recorder, pay-per-view, and spectrum mobile and spectrum guide services, as well as ad-supported free online video products. The company also provides Internet services, such as security suite that protects computers from viruses and spyware; in-home WiFi, which permits customers to lease high performance wireless routers to enhance their in-... view company details
Cemtrex, Inc. primarily provides electronic manufacturing services. The company operates through three segments: Advanced Technologies, Electronics Manufacturing, and Industrial Technology. The Advanced Technologies segment provides SmartDesk, an IoT product for the desktop PC market; and related white glove installation, extended warranties, and accessories directly to consumers, as well as through value added resellers for enterprises. This segment also offers design and development solutions to create impactful experiences for mobiles, Web, virtual and augmented reality, wearables, and tele... view company details
Deluxe Corporation provides checks, forms, marketing solutions, accessories, and other products and services for small businesses and financial institutions. It operates through three segments: Small Business Services, Financial Services, and Direct Checks. The company provides checks; printed forms, such as deposit tickets, billing forms, work orders, job proposals, purchase orders, invoices, and personnel forms, as well as computer forms and check registers; and accessories and other products comprising envelopes, office supplies, ink stamps, and labels, as well as checkbook covers. It also ... view company details
Digital Ally, Inc. produces and sells digital video imaging and storage products for use in law enforcement, security, and commercial applications in the United States and internationally. Its digital audio/video recording, storage, and other products include an in-car digital audio/video recorder that is contained in a rear view mirror for law enforcement vehicles and commercial fleets; and hands-free automatic activated body-worn cameras and in-car video systems, as well as provides its law enforcement customers with audio/video surveillance from multiple vantage points. The company also pro... view company details
ImageWare Systems, Inc. provides biometrically enabled software-based identity management solutions worldwide. Its flagship product is the IWS Biometric Engine, a multi-biometric software platform that enables the enrollment and management of unlimited population sizes. The company also offers GoMobile Interactive that enables business, service, and content providers to offer users biometric security for their products, services, and content; IWS PIV (personal identity verification) Management Application that supplies Web-based graphical user interface to server functions; IWS PIV Middleware,... view company details